Disposition of 14C-LY3009104 Following Oral Administration in Healthy Human Subjects
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
This is a single dose study of radiolabeled [14C]-LY3009104 in healthy male volunteers to
study the absorption, distribution, metabolism, and elimination of LY3009104. This study
requires minimum of 7 days and maximum of 22 days stay. This study is for research purposes
only and is not intended to treat any medical condition.